INNOSCIENCE (02577): Partial exercise of the over-allotment option, stabilization action and the stabilization period has ended.
Yingnuo Saiko (02577) announced that the rights issue as stated in the prospectus has been exercised on January 22, 2025.
INNOSCIENCE (02577) announced that the oversubscription rights as stated in the prospectus have been partially exercised by the stabilizing price operator (on behalf of itself and the underwriters of the oversubscribed shares) on January 22, 2025 (Wednesday), involving a total of 1.6644 million H shares, representing approximately 3.67% of the total number of shares available for subscription under the global offering before any exercise of oversubscription rights.
The oversubscribed shares will be distributed and issued by the company at a price of HK$30.86 per H share. The oversubscribed shares will be used to facilitate the delivery of a portion of the shares to cornerstone investors who have agreed to defer the delivery of their subscribed shares under the global offering.
Additionally, the stabilization period for the global offering ended on January 22, 2025 (Wednesday) (i.e. the 30th day after the deadline for submitting the Hong Kong public offering application).
Related Articles

New stock news | Hesai (02525) listed on the HKEX main board leading the global intelligent future with Siasun Robot & Automation perception technology.
Strengthening the synergy between IP and landmarks, STARPLUS LEGEND (06683) strategically invested in the Bird's Nest operating company.

IVD MEDICAL(01931) reached a significant strategic cooperation with Renhe International to jointly build the world's first vertical RWA exchange focusing on the OTC field.
New stock news | Hesai (02525) listed on the HKEX main board leading the global intelligent future with Siasun Robot & Automation perception technology.

Strengthening the synergy between IP and landmarks, STARPLUS LEGEND (06683) strategically invested in the Bird's Nest operating company.
IVD MEDICAL(01931) reached a significant strategic cooperation with Renhe International to jointly build the world's first vertical RWA exchange focusing on the OTC field.
